Codes ATC:
L01DB02
EMLc
Indication
Acute myeloid leukaemia with recurrent genetic abnormalities
Code ICD11:
2B30.0
INN
Daunorubicin
Type de médicament
Chemical agent
Type de liste
Liste complémentaire
(EML)
(EMLc)
(EMLc)
Formulations
Parenteral > General injections > IV:
50 mg in vial (as hydrochloride) powder for injection ;
20 mg in vial (as hydrochloride) powder for injection ;
2 mg per mL in vial (as hydrochloride) ;
5 mg per mL in vial (as hydrochloride)
Historique des statuts LME
Sexe
Tous
Âge
Aussi recommandé pour les enfants
Équivalence thérapeutique
La recommandation concerne ce médicament spécifique
Renseignements sur le brevet
Patents have expired in most jurisdictions
Lire la suite
sur les brevets.
Résumé des preuves et recommandation du comité d'experts
Following the review of the age-appropriateness of formulations on the EMLc, the Expert Committee recommended the addition of additional formulations of daunorubicin (injection 2 mg/mL and 5 mg/mL in vial and powder for injection 20 mg in vial) to the EML and EMLc.